top of page
Search

Kras Kickers at the 2020 National Lung Cancer Round Table 

Updated: Feb 3, 2020

KRas Kickers will be attending the 2020 National Lung Cancer Roundtable to represent the 25% of the lung cancer patients with a Kirsten rat sarcoma (KRAS) mutation. A comprehensive biomarker test should be completed by a doctor to identify cancer mutations.


Three of the four most deadly U.S. cancers (lung, colon and pancreatic) have a KRAS mutation. There are no specific drugs for KRAS cancers, more research is crucial.


KRasKickers.org is a patient driven conduit advocating for treatments, sharing knowledge & clinical trials for KRAS lung cancer patients pleading to Kick Cancers K Ras!!






 
 
Black capitalized text that reads, "Revolution Medicine."
Blue capitalized text on a gray background. Text reads, "Amgen."
Genentech_Logo.png_dark blue text that reads, "Genetech." Gray italicized text that reads, "a member of the Roche Group."
Dark blue text on top of sea foam text. Text reads, "Verastem Oncology."
bottom of page